1. A genetic risk score predicts de novo hepatocellular carcinoma in hepatits c cirrhotic patients treated with direct-acting antivirals. (February 2020) Authors: Degasperi, E.; Galmozzi, E.; Pelusi, S.; D'Ambrosio, R.; Soffredini, R.; Borghi, M.; Perbellini, R.; Facchetti, F.; Iavarone, M.; Sangiovanni, A.; Valenti, L.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ascent velocity and dynamics of the Fiumicino mud eruption, Rome, Italy. Issue 15 (4th August 2015) Authors: Vona, A.; Giordano, G.; De Benedetti, A. A.; D'Ambrosio, R.; Romano, C.; Manga, M. Journal: Geophysical research letters Issue: Volume 42:Issue 15(2015:Aug.) Page Start: 6244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Changes of AFP and PIVKA-II levels during DAA treatment and their predictive value for early diagnosis of HCC in HCV cirrhotic patients with SVR to DAA treatment. Issue 1 (February 2018) Authors: Sangiovanni, A.; D'Ambrosio, R.; Lunghi, G.; Bruccoleri, M.; Alimenti, E.; Borghi, M.; Perbellini, R.; Aghemo, A.; Iavarone, M.; Colombo, M.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance. (February 2019) Authors: Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Aragri, M.; Paolucci, S.; Masetti, C.; D'Ambrosio, R.; Degasperi, E.; Polilli, E.; Palitti, V. Pace; Fiorentino, G.; Foroghi, L.; Cento, V.; Scutari, R.; Bruzzone, B.; Calvaruso, V.; Coppola, N.; Gaeta, G.B.; Morsica, G.; Ghisetti, V. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chemokine changes during direct antiviral agents (DAA) therapy in patients with HCV infection or reinfection after liver transplantation: preliminary insights on their possible correlates. (February 2019) Authors: Colucci, G.; Donato, M.F.; D'Ambrosio, R.; Invernizzi, F.; Degasperi, E.; Perbellini, R.; Lunghi, G.; Uceda, S.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cirrhosis regression does not prevent hepatocellular carcinoma in patients with a sustained virological response to IFN. Issue 1 (16th February 2017) Authors: D'Ambrosio, R.; Aghemo, A.; Degasperi, E.; Sangiovanni, A.; Rumi, M.G.; Fraquelli, M.; Perbellini, R.; Bedossa, P.; Colombo, M.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical but not genetic variables predict the development of hepatocellular carcinoma in hepatitis C cirrhotic patients treated with direct acting antivirals: a 3-year study in 509 patients. (February 2019) Authors: Degasperi, E.; Galmozzi, E.; Facchetti, F.; D'Ambrosio, R.; Soffredini, R.; Borghi, M.; Perbellini, R.; Iavarone, M.; Sangiovanni, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study. (15th February 2015) Authors: Piscaglia, F.; Baroni, G. Svegliati; Barchetti, A.; Pecorelli, A.; Marinelli, S.; Tiribelli, C.; Bellentani, S.; Bolondi, L.; Zoli, M.; Malagotti, D.; Brandi, G.; Bugianesi, E.; Vanni, E.; Mezzabotta, L.; Cabibbo, G.; Petta, S.; Fracanzani, A.; Fargion, S.; Marra, F.; Fani, B. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical utility of a targeted panel sequencing for the diagnosis of chronic hereditary liver diseases in adult patients. (March 2023) Authors: Marini, I.; Ronzoni, L.; Pelusi, S.; Golfetto, F.S.; Lombardi, A.; Rondena, J.; Periti, G.; Bianco, C.; Passignani, G.; Castronovo, P.; D'Ambrosio, R.; Finelli, P.; Prati, D.; Valenti, L. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Coagulation balance and liver damage in non-cirrhotic patients with chronic hepatitis C after eradication by Direct-acting Antiviral Agents (DAAs). (March 2021) Authors: Sigon, G.; D'Ambrosio, R.; Clerici, M.G.; Pisano, G.; Chantarangkul, V.; Sollazzi, R.; Cespiati, A.; Iuculano, F.; Lombardi, R.; Peyvandi, F.; Lampertico, P.; Fargion, S.; Tripodi, A.; Fracanzani, A.L. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗